TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8206773

Group type: EXPERIMENTAL
Intervention: Nurse-delivered smoking cessation intervention (three structured sessions during hospitalization, followed by weekly phone calls for 5 weeks after discharge)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Nurse-delivered smoking cessation intervention (specific to cardiovascular unit)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Nurse-delivered smoking cessation intervention (specific to oncology unit)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Nurse-delivered smoking cessation intervention (specific to general surgical unit)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Nurse-delivered smoking cessation intervention (regardless of group assignment)
Number of subjects: 80
Study: 3207608

Group type: EXPERIMENTAL
Intervention: Chemotherapy (CT) with or without radiotherapy (RT)
Number of subjects: 1996

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT)
Number of subjects: 1996

Group type: EXPERIMENTAL
Intervention: Chemotherapy (CT)
Number of subjects: 1996

Group type: EXPERIMENTAL
Intervention: Overall treatment (CT, RT, or both)
Number of subjects: 1996
Study: 29459462

Group type: EXPERIMENTAL
Intervention: CABG+medical therapy (MED)
Number of subjects: 1212

Group type: COMPARATOR
Intervention: MED alone
Number of subjects: 1212

Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 1212
Study: 28885964

Group type: EXPERIMENTAL
Intervention: Hypoxia at moderate altitude (7,000 feet)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (normal conditions)
Number of subjects: 36
Study: 26316013

Group type: EXPERIMENTAL
Intervention: RAPID‐3
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CDAI
Number of subjects: 100
Study: 23506125

Group type: EXPERIMENTAL
Intervention: PARO (companion robot)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Reading group (control)
Number of subjects: 18
Study: 21380967

Group type: EXPERIMENTAL
Intervention: High-intensity strength training (HIS)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control class (no intervention)
Number of subjects: 32
Study: 18463831

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) guided antibiotic therapy (duration: 5.9±1.7 days)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Standardized duration of antibiotic therapy (control group, duration: 7.9±0.5 days)
Number of subjects: 110
Study: 16512971

Group type: EXPERIMENTAL
Intervention: propofol/remifentanil (0.5‐1.0 microg kg(‐1) min(‐1))
Number of subjects: 50

Group type: COMPARATOR
Intervention: propofol/sufentanil (30‐40 ng kg(‐1) min(‐1))
Number of subjects: 50
Study: 12800864

Group type: EXPERIMENTAL
Intervention: sport-specific resistance training
Number of subjects: 14

Group type: COMPARATOR
Intervention: control group
Number of subjects: 14
Study: 11140218

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0
Study: 9033890

Group type: EXPERIMENTAL
Intervention: 0.1% indomethacin/gentamicin
Number of subjects: 202

Group type: COMPARATOR
Intervention: 0.1% dexamethasone/neomycin
Number of subjects: 202
Study: 2060559

Group type: COMPARATOR
Intervention: Paracetamol 1.0 g
Number of subjects: 12

Group type: COMPARATOR
Intervention: Paracetamol 1.0 g plus codeine 60 mg
Number of subjects: 12
Study: 6197558

Group type: EXPERIMENTAL
Intervention: Obsidan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novocainamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 4028621

Group type: EXPERIMENTAL
Intervention: Aqueous methyl nicotinate (0, 0.1, 1.0, 10.0, and 100 mmol/L) with oral pretreatment of 25 mg doxepin hydrochloride
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Aqueous methyl nicotinate (0, 0.1, 1.0, 10.0, and 100 mmol/L) with oral pretreatment of 600 mg ibuprofen
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Aqueous methyl nicotinate (0, 0.1, 1.0, 10.0, and 100 mmol/L) with oral pretreatment of 50 mg indomethacin
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Aqueous methyl nicotinate (0, 0.1, 1.0, 10.0, and 100 mmol/L) with oral pretreatment of 975 mg aspirin
Number of subjects: 5

Group type: COMPARATOR
Intervention: Aqueous methyl nicotinate (0, 0.1, 1.0, 10.0, and 100 mmol/L) with oral pretreatment of lactose placebo
Number of subjects: 5
Study: 29688502

Group type: EXPERIMENTAL
Intervention: Subcutaneous semaglutide 0.5 mg once weekly
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Subcutaneous semaglutide 1.0 mg once weekly
Number of subjects: 397

Group type: COMPARATOR
Intervention: Volume-matched placebo
Number of subjects: 397
Study: 26487153

Group type: EXPERIMENTAL
Intervention: Abduction group (arm abducted at 90°)
Number of subjects: 481

Group type: COMPARATOR
Intervention: Neutral group (arms kept by the side)
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: Abduction group
Number of subjects: 481

Group type: COMPARATOR
Intervention: Neutral group
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 481
Study: 25461372

Group type: EXPERIMENTAL
Intervention: Leuprorelin
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Triptorelin
Number of subjects: 302

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 302
Study: 22571200

Group type: EXPERIMENTAL
Intervention: MPR-R (melphalan-prednisone-lenalidomide induction followed by lenalidomide maintenance)
Number of subjects: 459

Group type: COMPARATOR
Intervention: MPR (melphalan-prednisone-lenalidomide)
Number of subjects: 459

Group type: COMPARATOR
Intervention: MP (melphalan-prednisone)
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: MPR-R
Number of subjects: 459

Group type: COMPARATOR
Intervention: MPR
Number of subjects: 459

Group type: COMPARATOR
Intervention: MP
Number of subjects: 459
Study: 20505674

Group type: EXPERIMENTAL
Intervention: Candesartan 8 mg once a day, titrated to 16 mg after 1 month
Number of subjects: 194

Group type: COMPARATOR
Intervention: Olmesartan 10 mg once a day, titrated to 20 mg after 1 month
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 194
Study: 18249508

Group type: EXPERIMENTAL
Intervention: Good Behavior Game (GBG)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Intervention aimed at academic achievement
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard program of the school system
Number of subjects: 19
Study: 15720844

Group type: EXPERIMENTAL
Intervention: FP strategy (history and examination) on Day 1
Number of subjects: 200

Group type: COMPARATOR
Intervention: GUM strategy (near-patient microscopy) on Day 1
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: GUM strategy (near-patient microscopy) on Day 7
Number of subjects: 200

Group type: COMPARATOR
Intervention: FP strategy (history and examination) on Day 7
Number of subjects: 200
Study: 12627985

Group type: EXPERIMENTAL
Intervention: Topiramate 200 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topiramate 400 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lamotrigine 500 mg/day
Number of subjects: 0
Study: 10534795

Group type: EXPERIMENTAL
Intervention: Cough threshold measured with citric acid aerosols
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Cough threshold in smokers with SCI
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Cough threshold in smokers without SCI
Number of subjects: 44
Study: 8739928

Group type: EXPERIMENTAL
Intervention: Dextran infusion (7 ml/kg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Ringer's acetate
Number of subjects: 26
Study: 1873454

Group type: COMPARATOR
Intervention: Minimal intervention (one single counselling session and a brief handout on quitting techniques)
Number of subjects: 923

Group type: EXPERIMENTAL
Intervention: Repeated counselling (reinforcing sessions at Months 1, 3, 6, and 9)
Number of subjects: 923

Group type: EXPERIMENTAL
Intervention: Repeated counselling and use of nicotine gum
Number of subjects: 923

Group type: EXPERIMENTAL
Intervention: Repeated counselling and spirometry
Number of subjects: 923
Study: 6867983

Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol 200 micrograms
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol 400 micrograms
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol 800 micrograms
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol 1600 micrograms
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol (all doses)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Simple spirometric tests
Number of subjects: 8
Study: 30653490

Group type: EXPERIMENTAL
Intervention: AmBisome monotherapy (40 mg/kg)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: AmBisome (30 mg/kg) with miltefosine (100 mg/day for 28 days)
Number of subjects: 58
Study: 28070922

Group type: EXPERIMENTAL
Intervention: Hopping and jumping training programme (HJP)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Sensorimotor rehabilitation programme (SRP)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3
Study: 27418594

Group type: EXPERIMENTAL
Intervention: Dalcetrapib
Number of subjects: 5414

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5414
Study: 24694769

Group type: EXPERIMENTAL
Intervention: Triple antiplatelet therapy (TAT; DAT with cilostazol)
Number of subjects: 914

Group type: COMPARATOR
Intervention: Dual antiplatelet therapy (DAT; aspirin and clopidogrel)
Number of subjects: 914
Study: 22480130

Group type: EXPERIMENTAL
Intervention: Fentanyl buccal tablet (FBT) in doses proportional to daily opioid doses (group P)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Dose titration of FBT starting with an initial dose of 100 µg (group T)
Number of subjects: 82
Study: 20702512

Group type: EXPERIMENTAL
Intervention: Tai chi exercise (60 minutes/session, three sessions/week, n = 30)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (n = 31)
Number of subjects: 61
Study: 18566931

Group type: EXPERIMENTAL
Intervention: Short exercise technique (15-minute sessions of short steps with arms unsupported)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both stepping techniques (Short and Full)
Number of subjects: 0
Study: 16195824

Group type: EXPERIMENTAL
Intervention: 3.75 mg of GnRH agonist triptorelin acetate depot (Group I)
Number of subjects: 81

Group type: COMPARATOR
Intervention: 0.1 mg triptorelin acetate daily (Group II)
Number of subjects: 81
Study: 11788184

Group type: EXPERIMENTAL
Intervention: Continuous estrogen-progestin therapy (Conjugated Equine Estrogens and Medroxyprogestin without interruption)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Sequential regimen (Conjugated Equine Estrogens over 25 days with Medroxyprogestin beyond the 14th day)
Number of subjects: 104
Study: 9494450

Group type: EXPERIMENTAL
Intervention: Cromolyn sodium
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control
Number of subjects: 10
Study: 8067712

Group type: EXPERIMENTAL
Intervention: Propionibacterium granulosum KP-45, 10 mg administered intravenously between the seventh and third day prior to surgical treatment.
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Propionibacterium granulosum KP-45 (treatment group)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 101
Study: 2926518

Group type: EXPERIMENTAL
Intervention: Exercise (10-minute per day home training program for six weeks)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 45
Study: 1092425

Group type: EXPERIMENTAL
Intervention: Nimorazole (1 g orally at 12-hourly intervals for three doses)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Metronidazole (200 mg three times daily for 7 days)
Number of subjects: 100
Study: 30375890

Group type: EXPERIMENTAL
Intervention: Flaxseed (15g daily for 7 weeks)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control (usual diet)
Number of subjects: 99
Study: 28697832

Group type: EXPERIMENTAL
Intervention: Clonidine transdermal patch
Number of subjects: 134

Group type: COMPARATOR
Intervention: Haloperidol tablets
Number of subjects: 134
Study: 28586587

Group type: EXPERIMENTAL
Intervention: Laser Myringotomy (LM)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Ventilation Tubes (VT)
Number of subjects: 130
Study: 24433324

Group type: EXPERIMENTAL
Intervention: Contact force (CF) catheter (SmartTouch Thermocool, Biosense Webster)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-CF open‐irrigated catheter (EZ Steer Thermocool, Biosense Webster)
Number of subjects: 60
Study: 22285857

Group type: EXPERIMENTAL
Intervention: Inorganic nitrate (8 mmol KNO3)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (8 mmol KCl)
Number of subjects: 14
Study: 18692790

Group type: EXPERIMENTAL
Intervention: Combined hormone therapy (5 microg of ethinyl E(2) and 1 mg of norethindrone acetate)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 17717453

Group type: EXPERIMENTAL
Intervention: Intramedullary nailing
Number of subjects: 165

Group type: COMPARATOR
Intervention: External fixation
Number of subjects: 165
Study: 15313106

Group type: EXPERIMENTAL
Intervention: Print program
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Print plus Telephone program
Number of subjects: 399
Study: 11806479

Group type: EXPERIMENTAL
Intervention: 3% hydrogen peroxide in experimental dentifrice
Number of subjects: 4

Group type: COMPARATOR
Intervention: 3% hydrogen peroxide with 5% baking soda in experimental dentifrice
Number of subjects: 4
Study: 9286859

Group type: EXPERIMENTAL
Intervention: Antenatal betamethasone (12 mg at a 12-h interval)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no medical or obstetric problems)
Number of subjects: 46
Study: 8142112

Group type: EXPERIMENTAL
Intervention: Topical retinoids
Number of subjects: 0
Study: 2958072

Group type: EXPERIMENTAL
Intervention: Betahistine (H1-receptor agonist)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Histamine (combined H1- and H2-receptor agonist)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Impromidine (H2-receptor agonist)
Number of subjects: 15
Study: 30031389

Group type: EXPERIMENTAL
Intervention: Daily oral dosages of 800 IU vitamin D3
Number of subjects: 60

Group type: COMPARATOR
Intervention: Single oral dose of 300,000 IU vitamin D3
Number of subjects: 60
Study: 27179738

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 18140

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 18140
Study: 25291578

Group type: EXPERIMENTAL
Intervention: 3.75 µg of avian influenza Anhui vaccine with MF59 adjuvant
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: 3.75 µg of avian influenza Anhui vaccine without MF59 adjuvant
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: 7.5 µg of antigen with MF59 adjuvant
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: 90 µg of unadjuvanted vaccine
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: 7.5 µg plus adjuvant
Number of subjects: 637

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 637
Study: 22893166

Group type: EXPERIMENTAL
Intervention: COPE plus usual treatment (n = 55)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Usual treatment alone (control) (n = 48)
Number of subjects: 103
Study: 20832701

Group type: EXPERIMENTAL
Intervention: Acetazolamide 85 mg
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Ibuprofen 600 mg
Number of subjects: 343

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 343
Study: 18318243

Group type: EXPERIMENTAL
Intervention: Japanese SF-36v2 acute form
Number of subjects: 210
Study: 16650180

Group type: EXPERIMENTAL
Intervention: Levocetirizine, 5 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12477703

Group type: EXPERIMENTAL
Intervention: 'outside head' voices
Number of subjects: 12

Group type: COMPARATOR
Intervention: 'inside head' voices
Number of subjects: 12
Study: 10805616

Group type: EXPERIMENTAL
Intervention: Paroxetine up to 20 mg/day
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 8859144

Group type: EXPERIMENTAL
Intervention: Breakfast at school (200 ml of 3%-fat milk and 30 g of sugared cornflakes for 14 days)
Number of subjects: 569

Group type: COMPARATOR
Intervention: Breakfast at home
Number of subjects: 569

Group type: COMPARATOR
Intervention: No breakfast
Number of subjects: 569

Group type: EXPERIMENTAL
Intervention: Eating breakfast 2 hours prior to testing
Number of subjects: 569

Group type: EXPERIMENTAL
Intervention: Food supplementation 30 minutes prior to testing
Number of subjects: 569
Study: 8218759

Group type: EXPERIMENTAL
Intervention: Continuous infusion of ranitidine (50 mg bolus + 0.125 mg.kg/h)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Repeated boluses of ranitidine (50 mg every 6 h)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Baseline period (no treatment)
Number of subjects: 18
Study: 3493738

Group type: EXPERIMENTAL
Intervention: cyclosporin A (CyA) 5 mg/kg body weight for six months
Number of subjects: 14

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14
Study: 31364472

Group type: EXPERIMENTAL
Intervention: Direct clinical examination by three different examiners in Phase 1
Number of subjects: 187

Group type: COMPARATOR
Intervention: Video interpretation of eye examinations by two examiners in Phase 2
Number of subjects: 187
Study: 29569459

Group type: EXPERIMENTAL
Intervention: Video Eyeglasses/Earphones System (VEES)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Traditional non-aversive behaviour management
Number of subjects: 36
Study: 26756214

Group type: EXPERIMENTAL
Intervention: Stretching performed by flexing the hip while keeping the knee extended (SH)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Stretching performed by first flexing the hip with a flexed knee and then extending the knee (SK)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 111
Study: 24342421

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 967

Group type: COMPARATOR
Intervention: Control group (threshold score of 8)
Number of subjects: 967

Group type: COMPARATOR
Intervention: Control group (higher thresholds of 12, 16, and 20)
Number of subjects: 967
Study: 21692633

Group type: EXPERIMENTAL
Intervention: Human demineralized bone matrix putty with one size of bone particles (SPS)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Human demineralized bone matrix putty with two different sizes of bone particles (MPS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both groups (SPS and MPS)
Number of subjects: 20
Study: 19713332

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch 130/0.4 (Voluven)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 4% succinylated gelatin (Gelofusine)
Number of subjects: 90
Study: 17125809

Group type: EXPERIMENTAL
Intervention: Mass drug administration (MDA) programme against filariasis
Number of subjects: 2319
Study: 15235203

Group type: EXPERIMENTAL
Intervention: Early postoperative naso‐gastric tube feeding with a balanced diet formula
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional regimen of intravenous fluid administration (Control)
Number of subjects: 200
Study: 12217069

Group type: EXPERIMENTAL
Intervention: Scapula taping
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control condition (no scapula taping)
Number of subjects: 8
Study: 9631904

Group type: EXPERIMENTAL
Intervention: Same-day discharge haemorrhoidectomy (DAY)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Traditional hospital stay haemorrhoidectomy (STAY)
Number of subjects: 54
Study: 8174993

Group type: EXPERIMENTAL
Intervention: ondansetron
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 3163538

Group type: EXPERIMENTAL
Intervention: Ibuprofen (1600 mg/day)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ibuprofen (1600 mg/day) plus Meptazinol (400 mg/day)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 30446471

Group type: EXPERIMENTAL
Intervention: Water vapor thermal therapy (Rezūm procedure)
Number of subjects: 1295

Group type: COMPARATOR
Intervention: Doxazosin
Number of subjects: 1295

Group type: COMPARATOR
Intervention: Finasteride
Number of subjects: 1295

Group type: COMPARATOR
Intervention: Combination drug therapy
Number of subjects: 1295

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1295
Study: 27661412

Group type: EXPERIMENTAL
Intervention: miR-16-5p
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: miR-106a-5p
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: miR-223-3p
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: miR-652-3p
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: miR-199a-3p
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: miR-18a-5p
Number of subjects: 100
Study: 25579623

Group type: EXPERIMENTAL
Intervention: Group medical consultations (GMCs)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Individual outpatient visits
Number of subjects: 69
Study: 23064593

Group type: EXPERIMENTAL
Intervention: Prone position with table flat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prone position with table tilted
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prone position flat vs. prone position tilted
Number of subjects: 0

Group type: COMPARATOR
Intervention: Correlation with BMI
Number of subjects: 0
Study: 20875125

Group type: EXPERIMENTAL
Intervention: Immediate treatment group (lunchtime walking intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed treatment control group
Number of subjects: 0
Study: 18230943

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Rogerian Supportive Therapy (ST)
Number of subjects: 60
Study: 16698318

Group type: EXPERIMENTAL
Intervention: Epsilon amino-caproic acid (EACA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Autologous transfusion (AT)
Number of subjects: 60
Study: 14639584

Group type: EXPERIMENTAL
Intervention: Enzyme replacement therapy (ERT) with 0.2 mg/kg of alpha‐galactosidase A every 2 weeks
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Enzyme replacement therapy (ERT)
Number of subjects: 26
Study: 10952699

Group type: EXPERIMENTAL
Intervention: Fluid restriction (about 80% of standard input)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Standard fluid volumes (60 ml/kg on day 1 progressing to 150 ml/kg on day 7)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Fluid restriction
Number of subjects: 168

Group type: COMPARATOR
Intervention: Standard fluid volumes
Number of subjects: 168